Joint Programming Initiative “A Healthy Diet for a Healthy Life’ (JPI HDHL) Call 2022 (NUTRIMMUNE)

The Joint Programming Initiative “A Healthy Diet for a Healthy Life" (JPI HDHL) has been established to coordinate research in the areas of nutrition and health in order to achieve tangible societal and health impact and to strengthen European leadership and competitiveness in this field. Poor diets and nutrition are major drivers of non-communicable diseases (NCDs).  The COVID-19 pandemic clearly showed the critical interplay between diet-related metabolic diseases and infectious diseases: metabolic diseases such as obesity and type 2 diabetes increased the severity of COVID-19 infection. In addition to this, the current pandemic highlighted the impact of health inequalities. This emphasised the importance of needing to better understand the role of nutrition in immune function, resilience and dysfunction, and its interplay between diet-related- metabolic and infectious diseases. This JPI HDHL call aims to support transnational, collaborative research projects that gain a better understanding of the interactions between nutrition and immunity within the context of its interplay between infectious diseases and diet-related metabolic diseases.

Additional Information

This call aims to address the relationship between nutrition, immunity (including inflammatory component) and human health by funding top-class transnational and transdisciplinary research consortia.

Proposals should focus on one or both of the following topics:

  • Establishing the cause-and-effect relationship between nutrition, immune function and infectious diseases in the context of diet-related metabolic disorders.
  • Development of innovative food solutions. 

Important note:

Under HRB national rules the following eligibility criteria apply:

  • The scope of the call includes only "Establishing the cause-and-effect relationship between nutrition, immune function and infectious diseases in the context of diet-related metabolic disorders"
  •  Proposals addressing “Development of innovative food solutions” are ineligible.

For proposals addressing the topic “Development of innovative food solutions” Irish applicants are advised that funding is available from the funding organisation Department of Agriculture, Food and the Marine (DAFM). 


This is a joint transnational call: applicants must apply as part of a transnational consortium.

Researchers from Ireland can apply as coordinators or partners. If successful, researchers from Ireland will be funded by the Health Research Board up to the maximum amount for the call. Applicants applying for funding from Ireland must be based at an eligible HRB Host Institution. 

The following conditions apply to the composition of consortia:

  • Minimum of three partners from three different participating countries. These three partners should be eligible for funding by one of the participating organisations.
  • No more than two eligible partners can originate from the same country.
  • Maximum of six eligible partners per consortium.
  • Total size of consortium cannot exceed eight applicants (including researchers that participate as collaborators).

The following conditions apply to collaborators:

  • Clear added value for the research project. This must be demonstrated in the application.
  • Secure own funding for participation with clear evidence in the proposal that this is already in place
  • Maximum of two collaborators per consortium
  • The majority of the consortia members should be eligible for funding by the participating funders.

Individual country partners/coordinators should confirm eligibility with their national funding organisation contact point.  


Electronic proposal submission is mandatory via the electronic submission system 

Full details on the call for proposals, including scope of the call, evaluation process, eligible costs and participating countries are available on JPI HDHL NUTRIMMUNE (2022).  Applicants from Ireland must read the HRB Guidance notes and FAQ’s for the scheme. Eligibility requirements from applicants from Ireland will apply.

  • Whilst applications will be submitted jointly by groups from different countries, individual research groups in successful projects will be funded by the individual JPI HDHL funding organisation(s) within their country.

This call uses a single submission procedure (full proposals), including a rebuttal stage.

The project coordinator and all principal investigators in the consortium must be registered at the JPI HDHL Meta Data Base before a proposal can be submitted. In addition, it is mandatory for all applicants to complete their profile information.

Proposals must be written in English and must be submitted to the Joint Call Secretariat (JCS) by the project coordinator via the electronic submission system  exclusively.


General enquiries: Joint Call Secretariat (JCS) at: Netherlands Organisation for Health Research and Development (ZonMw)

Dr. Wilke van Ansem & Larissa van der Bent

+31 (0)70 349 5 164 /+31 (0)70 349 391

Email: jpihdhl(at) 

Applicants from Ireland who still have questions after reading the information on the Call website and the HRB Guidance notes and HRB FAQ can contact: 

 Dr Louise Drudy at  HRB email:  eujointprogrammes(at)

Opening date
12:00 15-02-2022
Closing date
15:00 21-04-2022